Literature DB >> 18004779

Solution structure and neutralizing antibody binding studies of domain III of the dengue-2 virus envelope protein.

Kuo-Chun Huang1, Ming-Che Lee, Chih-Wei Wu, Kao-Jean Huang, Huan-Yao Lei, Jya-Wei Cheng.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18004779     DOI： 10.1002/prot.21806

Source DB:  PubMed          Journal:  Proteins        ISSN： 0887-3585


× No keyword cloud information.
  12 in total

1.  Mutations in the West Nile prM protein affect VLP and virion secretion in vitro.

Authors:  Amanda E Calvert; Claire Y-H Huang; Carol D Blair; John T Roehrig
Journal:  Virology       Date:  2012-07-31       Impact factor: 3.616

2.  Thioaptamers targeting dengue virus type-2 envelope protein domain III.

Authors:  Sai Hari A Gandham; David E Volk; Ganesh L R Lokesh; Muniasamy Neerathilingam; David G Gorenstein
Journal:  Biochem Biophys Res Commun       Date:  2014-09-26       Impact factor: 3.575

3.  Engineered Dengue Virus Domain III Proteins Elicit Cross-Neutralizing Antibody Responses in Mice.

Authors:  Julia C Frei; Ariel S Wirchnianski; Jennifer Govero; Olivia Vergnolle; Kimberly A Dowd; Theodore C Pierson; Margaret Kielian; Mark E Girvin; Michael S Diamond; Jonathan R Lai
Journal:  J Virol       Date:  2018-08-29       Impact factor: 5.103

Review 4.  Focus on flaviviruses: current and future drug targets.

Authors:  Brian J Geiss; Hillary Stahla; Amanda M Hannah; Amanda M Gari; Susan M Keenan
Journal:  Future Med Chem       Date:  2009-05       Impact factor: 3.808

5.  Structural optimization and de novo design of dengue virus entry inhibitory peptides.

Authors:  Joshua M Costin; Ekachai Jenwitheesuk; Shee-Mei Lok; Elizabeth Hunsperger; Kelly A Conrads; Krystal A Fontaine; Craig R Rees; Michael G Rossmann; Sharon Isern; Ram Samudrala; Scott F Michael
Journal:  PLoS Negl Trop Dis       Date:  2010-06-22

6.  Selection and Characterization of DNA Aptamers Targeting All Four Serotypes of Dengue Viruses.

Authors:  Heng-Li Chen; Wen-Hsin Hsiao; Hsiang-Chi Lee; Suh-Chin Wu; Jya-Wei Cheng
Journal:  PLoS One       Date:  2015-06-25       Impact factor: 3.240

Review 7.  Progress in the identification of dengue virus entry/fusion inhibitors.

Authors:  Carolina De La Guardia; Ricardo Lleonart
Journal:  Biomed Res Int       Date:  2014-07-24       Impact factor: 3.411

8.  Rational engineering of a human anti-dengue antibody through experimentally validated computational docking.

Authors:  Luca Simonelli; Mattia Pedotti; Martina Beltramello; Elsa Livoti; Luigi Calzolai; Federica Sallusto; Antonio Lanzavecchia; Luca Varani
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240

9.  Cross-reactivities between human IgMs and the four serotypes of dengue virus as probed with artificial homodimers of domain-III from the envelope proteins.

Authors:  Nora Zidane; Philippe Dussart; Laetitia Bremand; Hugues Bedouelle
Journal:  BMC Infect Dis       Date:  2013-07-01       Impact factor: 3.090

10.  Proteomic identification of dengue virus binding proteins in Aedes aegypti mosquitoes and Aedes albopictus cells.

Authors:  Maria de Lourdes Muñoz; Gustavo Limón-Camacho; Rosalinda Tovar; Alvaro Diaz-Badillo; Guillermo Mendoza-Hernández; William C Black
Journal:  Biomed Res Int       Date:  2013-11-10       Impact factor: 3.411
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.